← Back to Search

Trauma Informed Guilt Reduction Therapy for Guilt (TrIGR Trial)

N/A
Waitlist Available
Led By Sonya B. Norman, PhD
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether a 6-session psychotherapy intervention can help Veterans feel less deployment-related guilt and less distress related to their guilt.

Eligible Conditions
  • PTSD
  • Guilt
  • Shame

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Trauma Informed Guilt Reduction TherapyExperimental Treatment1 Intervention
6-session psychotherapy intervention
Group II: Supportive Care TherapyActive Control1 Intervention
6-session psychotherapy intervention

Find a Location

Who is running the clinical trial?

Providence VA Medical CenterFED
26 Previous Clinical Trials
72,265 Total Patients Enrolled
Brown UniversityOTHER
465 Previous Clinical Trials
698,842 Total Patients Enrolled
Seattle Institute for Biomedical and Clinical ResearchOTHER
53 Previous Clinical Trials
13,473 Total Patients Enrolled

Media Library

Trauma Informed Guilt Reduction Therapy Clinical Trial Eligibility Overview. Trial Name: NCT02512445 — N/A
Guilt Research Study Groups: Trauma Informed Guilt Reduction Therapy, Supportive Care Therapy
Guilt Clinical Trial 2023: Trauma Informed Guilt Reduction Therapy Highlights & Side Effects. Trial Name: NCT02512445 — N/A
Trauma Informed Guilt Reduction Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT02512445 — N/A
~19 spots leftby Nov 2025